BAY207543 (Bepanthol, Bepantol® Derma Spray)
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Skin Recovery
Conditions
Skin Recovery
Trial Timeline
Feb 11, 2019 → Mar 11, 2019
NCT ID
NCT03853525About BAY207543 (Bepanthol, Bepantol® Derma Spray)
BAY207543 (Bepanthol, Bepantol® Derma Spray) is a approved stage product being developed by Bayer for Skin Recovery. The current trial status is completed. This product is registered under clinical trial identifier NCT03853525. Target conditions include Skin Recovery.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03853512 | Approved | Completed |
| NCT03853525 | Approved | Completed |
| NCT03853538 | Approved | Completed |
Competing Products
20 competing products in Skin Recovery